Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,122
Active & Responsive
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
for
Non Small Cell Lung Cancer
Location: Philadelphia PA, New York NY, Buffalo NY, Pinehurst NC,
Sponsor: Ankyra Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT07027514
Phase 1, Recruiting
Active & Responsive
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Location: Philadelphia PA, New Brunswick NJ, Summit NJ,
Sponsor: Black Diamond Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07326566
Phase 2, Recruiting
Active & Responsive
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
Location: Philadelphia PA, New York NY, Fairfax VA, Fort Wayne IN,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07174583
Phase 1, Phase 2, Recruiting
Active & Responsive
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
for
Advanced Melanoma
Location: Philadelphia PA, New Brunswick NJ, New York NY,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT05549297
Phase 3, Recruiting
Active & Responsive
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
for
Age-Related Macular Degeneration
Location: Philadelphia PA, Boston MA, Ann Arbor MI, Oak Forest IL,
Sponsor: Astellas Institute for Regenerative Medicine
Sex: All
Age: 50+
Code: NCT03178149
Phase 1, Recruiting
Active & Responsive
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
for
Uveal Melanoma
Location: Philadelphia PA, Toronto, Nashville TN, Scottsdale AZ
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07804186
Phase 3, Recruiting
Active & Responsive
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Philadelphia PA, New York NY, Toms River NJ, Boston MA,